Seoul
South Korea
2
2011-08-25
2
2015-04-14
These are the the leading inventors for applications assigned to Daewon Pharm., Co., Ltd.:
Daewon Pharm., Co., Ltd. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Oral pharmaceutical formulation of pelubiprofen with improved dissolution rate and stability
#2 | 2010-06-24 ✅ Patent 8,008,272 granted on 2011-08-30Nuclease-resistant RNA aptamer inhibiting replication of hepatitis C virus replicon
205099 ⎘